Graves ophthalmopathy, strict

E4_GRAVES_OPHT_STRICT

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

786

4. Check minimum number of events

None

786

5. Include endpoints

None

786

6. Filter based on genotype QC (FinnGen only)

786

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF7

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3679 2975 690
Only index persons 3569 2906 663
Unadjusted period prevalence (%)
Whole population 0.07 0.09 0.02
Only index persons 0.09 0.11 0.03
Median age at first event (years)
Whole population 51.38 51.28 51.88
Only index persons 51.22 51.20 51.31

-FinnGen-

Key figures

All Female Male
Number of individuals 786 643 143
Unadjusted period prevalence (%) 0.19 0.22 0.06
Median age at first event (years) 52.41 51.98 54.33

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
675
Matched controls
6749
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
4503599627370496.0
323.0
668
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
89.3
323.0
356
83
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
461.6
323.0
580
88
H03BB01
ATC
carbimazole; oral
160.3
323.0
527
146
H03AA01
ATC
levothyroxine sodium; systemic
22.1
257.5
562
1240
BAA60
NOMESCO Finland
Total thyroidectomy
47.4
196.9
241
78
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
2197.1
176.0
163
*
H062, E050
ICD-10 Finland
NA
499.3
162.9
156
*
104
Kela drug reimbursment
Thyroid insufficiency
14.1
140.7
265
296
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
36.3
129.5
168
61
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
7.9
125.0
530
2127
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
163.8
106.7
110
8
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
56.3
85.7
101
21
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.9
81.8
415
1650
H53.2
ICD-10 Finland
Diplopia
20.9
77.2
117
67
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
44.0
76.9
95
25
H05.2
ICD-10 Finland
Exophthalmic conditions
97.8
71.7
78
9
C07AA05
ATC
propranolol; systemic
4.9
69.2
287
880
H50.2
ICD-10 Finland
Vertical strabismus
81.4
65.6
73
10
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
42.2
58.0
72
19
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.4
49.6
166
381
XCK00
NOMESCO Finland
Perimetry
7.1
49.5
131
222
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
+∞
48.5
46
*
H02AB06
ATC
prednisolone; systemic
3.2
45.5
430
2376
CAC44
NOMESCO Finland
Combined decompression of orbit
+∞
34.7
33
*
CEC00
NOMESCO Finland
Recession of extraocular muscle
68.8
34.4
39
6
CA1AD
NOMESCO Finland
Orbita CT
184.2
34.1
35
*
ZX120
NOMESCO Finland
Intravenous
4.5
34.0
132
344
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.5
31.9
100
206
ZXA10
NOMESCO Finland
Bilateral
3.2
31.5
197
761
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
31.4
181
659
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
12.9
30.3
54
45
H50.6
ICD-10 Finland
Mechanical strabismus
304.3
29.0
29
*
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
156.7
28.9
30
*
H50.8
ICD-10 Finland
Other specified strabismus
151.2
27.8
29
*
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
14.4
27.2
46
34
H50.0
ICD-10 Finland
Convergent concomitant strabismus
29.1
26.9
36
13
A02BC02
ATC
pantoprazole; systemic
2.6
26.8
501
3563
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
26.8
195
825
XCD10
NOMESCO Finland
Electrophysiological examination of eye
9.7
26.7
55
61
WF099
NOMESCO Finland
Other radiotherapy
54.0
26.4
31
6
CAC20
NOMESCO Finland
Lateral decompression of orbit
+∞
26.2
25
*
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
+∞
25.2
24
*
H02AB07
ATC
prednisone; oral
3.1
24.4
151
567
H04.10
ICD-10 Finland
Dry eye syndrome
3.5
24.3
124
405
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.2
24.1
143
522
2AB04
NOMESCO Finland
NA
90.0
23.8
26
*
T86
ICPC
Hypothyroidism/myxoedema
5.6
21.7
65
126
E03.89
ICD-10 Finland
Other specified hypothyroidism
5.8
21.3
62
116
T85
ICPC
Hyperthyroidism/thyrotoxicosis
18.0
20.2
31
18
C07AB07
ATC
bisoprolol; oral
2.2
20.0
334
2111
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.3
19.6
107
363
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
31.0
18.4
24
8
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
18.3
284
1714
H02.5
ICD-10 Finland
Other disorders affecting eyelid function
45.3
18.3
22
5
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.2
18.3
58
120
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
6.3
18.2
49
83
E05.5
ICD-10 Finland
Thyroid crisis or storm
184.6
17.6
18
*
Z3231
NOMESCO Finland
Registered nurse
2.2
17.3
213
1153
CEW99
NOMESCO Finland
Other operation on extraocular muscle
51.4
17.1
20
*
XCK10
NOMESCO Finland
Photography of fundus of eye
3.1
16.8
98
347
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
+∞
16.7
16
*
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
18.5
16.6
25
14
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.8
16.2
46
84
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
34.3
15.8
20
6
E03
ICD-10 Finland
Other hypothyroidism
3.5
15.5
76
238
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
18.3
15.2
23
13
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
46.1
15.1
18
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
14.9
296
1927
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
14.6
298
1953
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
14.6
217
1259
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
153.1
14.5
15
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
16.2
14.0
22
14
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.0
13.5
241
1492
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
18.7
13.4
20
11
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
13.3
80
289
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
10.8
12.8
24
23
N05CF01
ATC
zopiclone; oral
1.9
12.5
233
1457
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.4
12.3
60
188
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.4
12.2
61
194
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
7.8
11.2
25
33
CE2W4
NOMESCO Finland
Eye movement mapping
44.1
10.9
13
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
28.5
10.8
14
5
A11CC03
ATC
alfacalcidol; systemic
5.6
10.5
30
56
WX002
NOMESCO Finland
Sedation and analgesia
2.0
10.4
142
784
1XC02
NOMESCO Finland
NA
10.8
10.3
19
18
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
19.1
10.3
15
8
CS494
NOMESCO Finland
Other visual field testing
5.0
10.2
32
67
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
10.1
73
296
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
26.4
9.8
13
5
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
55.8
9.7
11
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.0
9.0
119
647
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
12.7
8.9
15
12
Z2221
NOMESCO Finland
Medical doctor
1.8
8.9
196
1273
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.5
8.8
30
69
WF002
NOMESCO Finland
Radical radiotherapy
3.4
8.8
41
125
H03BA02
ATC
propylthiouracil; oral
50.6
8.7
10
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
4.8
8.2
26
56
WX402
NOMESCO Finland
General anaesthesia
1.9
8.1
123
699
106
Kela drug reimbursment
Hypoparathyroidism
11.9
8.1
14
12
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
22.3
8.0
11
5
S01KA02
ATC
hypromellose; ophthalmic
5.0
8.0
24
49
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
8.6
7.8
16
19
CD2S4
NOMESCO Finland
Photography of eye
18.6
7.6
11
6
ZX050
NOMESCO Finland
Stereotactic radiotherapy
12.0
7.6
13
11
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
25.3
7.6
10
*
E05.89
ICD-10 Finland
Other thyrotoxicosis
10.2
7.6
14
14
A11CC02
ATC
dihydrotachysterol; oral
13.5
7.4
12
9
ZXE00
NOMESCO Finland
One hour or less
1.6
7.4
266
1955
H57.1
ICD-10 Finland
Ocular pain
3.3
7.3
35
110
E83.51
ICD-10 Finland
Hypocalcemia
11.0
7.3
13
12
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
7.3
91
481
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
4.6
6.8
22
49
H50.1
ICD-10 Finland
Divergent concomitant strabismus
9.4
6.8
13
14
H50.9
ICD-10 Finland
Strabismus, unspecified
40.4
6.8
8
*
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
40.4
6.8
8
*
H01CB02
ATC
octreotide; parenteral
22.8
6.7
9
*
S01EE01
ATC
latanoprost; ophthalmic
2.8
6.6
40
149
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.9
6.5
15
22
H50.52
ICD-10 Finland
Exophoria
6.9
6.5
15
22
ZXC95
NOMESCO Finland
Use of surgical navigator
5.8
6.5
17
30
ZXA00
NOMESCO Finland
Right side
1.6
6.5
174
1178
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
70.5
6.4
7
*
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
70.5
6.4
7
*
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
7.5
6.4
14
19
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
6.4
49
209
H02AB09
ATC
hydrocortisone; systemic
3.9
6.3
24
63
WX140
NOMESCO Finland
Parabulbar anesthesy
3.2
6.3
31
101
H50.50
ICD-10 Finland
Alternating hyperphoria
+∞
6.3
6
*
G73.0*E05.9
ICD-10 Finland
Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]
+∞
6.3
6
*
E50.0
ICD-10 Finland
Vitamin A deficiency with conjunctival xerosis
+∞
6.3
6
*
N07BA03
ATC
varenicline; oral
2.7
6.2
40
152
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
6.2
82
444
Z3226
NOMESCO Finland
Physiotherapist
1.7
6.2
124
772
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
6.2
75
391
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
6.2
153
1012
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.0
6.0
32
110

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
423
207
43.08
307.65
5.2
1.7
iu/l
6.0
5.2
0.35
299
68
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
408
471
16.93
307.65
7.8
3.0
pmol/l
4.6
4.5
0.09
386
409
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
766
5502
16.41
59.67
14.9
4.3
pmol/l
15.9
14.6
32.23
740
5040
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
178
577
3.70
46.45
1.4
1.2
iu/ml
218.7
148.4
1.23
78
243
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
509
3209
2.66
37.25
7.3
6.1
mmol/l
1.2
1.2
1.74
431
2691
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
468
2910
2.50
34.04
6.3
5.3
mmol/l
1.2
1.2
1.41
439
2625
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
770
6367
11.28
31.90
16.4
5.0
mu/l
1.6
2.1
1.54
745
5856
(3018418) pH of Serum or Plasma
345
1927
2.41
31.02
4.6
3.6
ph
7.4
7.4
1.16
58
367
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
138
504
3.11
28.84
2.9
3.5
ng/l
52.8
81.0
8.29
126
446
(3013650) Neutrophils [#/volume] in Blood by Automated count
552
3874
2.43
28.20
9.2
8.8
e9/l
3.9
4.0
0.69
483
3405
(3015377) Calcium [Moles/volume] in Serum or Plasma
369
2274
2.17
24.66
3.4
3.3
mmol/l
2.3
2.4
3.42
327
1997
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
430
2924
2.04
20.95
2.8
2.3
nmol/l
76.4
77.9
0.53
394
2629
(42870588) Differential panel, method unspecified - Blood
343
2167
2.03
20.35
5.3
5.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
288
1717
2.07
19.96
7.3
6.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
450
3173
1.98
19.08
5.7
5.8
%
28.5
28.7
0.12
428
2941
(3022096) Basophils/100 leukocytes in Blood
428
2970
1.97
18.98
5.7
5.7
%
0.7
0.7
0.20
405
2755
(3019069) Monocytes/100 leukocytes in Blood
440
3097
1.96
18.55
5.9
6.0
%
8.5
8.3
0.77
420
2889
(3006504) Eosinophils/100 leukocytes in Blood
438
3085
1.95
18.35
5.7
5.7
%
2.9
2.8
0.71
415
2853
(3001604) Monocytes [#/volume] in Blood
460
3305
1.94
18.04
5.7
5.6
e9/l
0.6
0.6
0.09
395
2869
(3018010) Neutrophils/100 leukocytes in Blood
442
3143
1.93
17.78
5.7
5.5
%
56.2
56.8
0.57
422
2927
(3013115) Eosinophils [#/volume] in Blood
473
3447
1.93
17.58
6.0
5.9
e9/l
0.2
0.2
1.30
406
3049
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
637
5169
2.23
17.31
8.7
7.0
u/l
75.9
77.1
0.24
618
4841
(3006315) Basophils [#/volume] in Blood
459
3324
1.92
17.26
5.8
5.6
e9/l
0.0
0.0
0.26
393
2886
(3019198) Lymphocytes [#/volume] in Blood
466
3394
1.92
17.19
5.7
5.6
e9/l
1.9
1.9
0.45
408
3009
(3036481) Cortisol [Moles/volume] in Serum or Plasma
134
651
2.28
15.23
2.4
2.1
nmol/l
360.9
374.3
0.38
123
600
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
32
69
4.79
14.11
3.8
4.5
u/ml
49.9
58.8
—
9
22
(3013707) Erythrocyte sedimentation rate by Westergren method
607
5041
1.90
12.58
4.6
4.1
mm/h
11.6
11.7
0.08
571
4649
(3013826) Glucose [Moles/volume] in Serum or Plasma
478
3737
1.71
11.78
4.5
4.2
mmol/l
6.4
6.6
1.08
449
3484
(3024561) Albumin [Mass/volume] in Serum or Plasma
365
2729
1.63
10.08
4.0
4.2
g/l
36.0
35.9
0.15
341
2546
(3021589) Normoblasts [#/volume] in Blood
391
2976
1.62
10.03
10.0
8.8
e9/l
0.0
0.0
0.39
310
2448
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
37
117
3.27
9.71
1.8
2.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
161
973
1.82
9.70
1.4
1.3
titre
369.7
537.7
1.02
33
224
(3019550) Sodium [Moles/volume] in Serum or Plasma
749
6883
2.87
9.69
17.0
13.9
mmol/l
139.9
139.7
1.28
736
6699
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
349
2599
1.62
9.68
2.1
1.9
pmol/l
98.3
97.6
0.09
172
1281
(3023103) Potassium [Moles/volume] in Serum or Plasma
750
6906
2.88
9.49
17.2
14.0
mmol/l
3.9
3.9
2.17
736
6709
(3052851) Hemolysis interference index of Serum or Plasma
48
185
2.70
8.92
2.1
3.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
104
566
1.97
8.60
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
235
1631
1.63
8.44
1.4
1.3
u/ml
1.3
1.4
0.07
54
444
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
730
6694
2.27
8.34
14.2
12.6
mg/l
21.6
21.1
0.14
577
5222
(3007164) IgA [Mass/volume] in Serum or Plasma
206
1390
1.65
8.24
1.5
1.5
g/l
2.2
2.3
0.41
108
853
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
690
6207
1.91
8.23
6.1
5.4
mmol/mol
38.9
39.3
0.64
653
5772
(3017143) Hepatitis C virus Ab [Presence] in Serum
121
714
1.82
7.79
1.4
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
716
6546
2.05
7.78
5.0
4.4
mmol/l
5.8
5.9
0.13
679
6009
(3021879) Hepatitis B virus core Ab [Presence] in Serum
87
462
1.99
7.70
1.3
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
85
451
1.99
7.54
2.1
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
179
1195
1.64
7.38
3.0
2.7
mmol/l
2.4
2.4
1.45
151
1054
(3030467) Casts [#/volume] in Urine by Automated count
236
1695
1.56
7.14
3.0
2.9
e6/l
0.2
0.4
1.35
170
1269
(3018095) Leukocytes [#/volume] in Urine
295
2230
1.52
7.04
3.9
3.5
e6/l
65.3
90.7
0.54
190
1539
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
17
39
4.43
6.99
6.1
6.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
700
6401
1.86
6.86
14.1
11.4
ml/min/173m2
83.9
82.8
0.75
609
5238
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
42
174
2.49
6.80
1.2
1.3
u/ml
55.5
42.4
—
5
19
(3044640) Blood type and Crossmatch panel - Blood
275
2063
1.51
6.74
2.2
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
24
74
3.31
6.60
1.5
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
149
984
1.63
6.34
1.4
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
167
1135
1.60
6.32
4.3
3.4
ng/l
245.2
295.0
0.10
133
811
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
527
4536
1.49
6.31
3.4
2.9
u/l
36.1
44.6
2.85
504
4252
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
759
7182
2.65
6.25
14.1
9.9
u/l
24.0
24.8
0.95
746
6938
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
214
1543
1.53
6.24
2.1
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
141
924
1.64
6.18
2.9
2.7
e6/l
4.6
3.3
0.42
73
475
(3033658) Prothrombin time (PT) actual/Normal
222
1618
1.52
6.14
4.3
3.3
%
92.5
96.0
1.22
217
1569
(36304419) Bacteria [Presence] in Urine
228
1675
1.51
6.06
3.1
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
174
1212
1.56
5.89
2.9
2.5
mosm/kgh2o
542.6
538.0
0.09
136
1042
(3012095) Magnesium [Moles/volume] in Serum or Plasma
148
995
1.60
5.83
3.5
3.0
mmol/l
0.8
0.8
0.11
132
933
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
99
600
1.74
5.79
2.2
2.3
u/l
28.3
38.1
1.73
85
507
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
19
58
3.33
5.33
1.2
1.1
nmol/l
1.3
1.2
—
6
6
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
145
996
1.56
5.18
2.7
2.5
e6/l
2.0
1.1
0.60
77
543
(3044889) 12 lead EKG panel
531
4682
1.41
4.82
3.9
3.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
238
1852
1.41
4.48
3.2
3.0
e6/l
39.2
56.2
0.36
173
1418
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
109
728
1.58
4.38
2.1
2.4
umol/l
5.8
6.7
0.63
89
624
(3039162) Centromere protein B Ab [Units/volume] in Serum
25
102
2.50
4.25
1.1
1.4
—
54.0
—
0
7
(3003458) Phosphate [Moles/volume] in Serum or Plasma
113
767
1.55
4.24
5.1
4.8
mmol/l
1.0
1.0
0.04
98
701
(3037467) Urinalysis macro (dipstick) panel - Urine
517
4585
1.37
4.21
4.6
4.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
160
1170
1.46
4.20
1.7
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
69
417
1.72
4.11
2.8
2.9
ng/l
161.6
168.6
0.06
61
387
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
48
3.17
3.94
1.9
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
274
2224
1.36
3.89
3.2
2.9
u/l
27.1
29.2
1.26
256
2121
(40761511) CBC panel - Blood by Automated count
738
7047
1.77
3.70
15.8
12.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
44
243
1.86
3.56
1.6
2.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
339
2872
1.32
3.51
2.2
2.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
771
7487
2.56
3.45
26.2
18.8
e9/l
261.0
257.8
0.77
757
7313
(3009542) Hematocrit [Volume Fraction] of Blood
661
6179
1.44
3.43
20.5
13.4
%
40.0
39.7
0.36
524
4542
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
39
210
1.90
3.41
1.7
1.6
—
166.7
—
0
9
(3024731) MCV [Entitic volume]
771
7491
2.53
3.37
26.0
18.8
fl
91.0
90.9
0.33
766
7390
(3035941) MCH [Entitic mass]
771
7491
2.53
3.37
26.0
18.7
pg
30.2
30.2
0.11
766
7389
(3026361) Erythrocytes [#/volume] in Blood
771
7492
2.52
3.35
26.1
18.8
e12/l
4.5
4.5
2.99
755
7299
(3019309) Folate [Moles/volume] in Red Blood Cells
148
1111
1.41
3.34
1.6
1.7
nmol/l
1055.7
1207.0
1.37
109
823
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
198
1560
1.36
3.34
2.6
2.1
mg/l
2.6
3.0
2.20
174
1320
(3010813) Leukocytes [#/volume] in Blood
771
7493
2.52
3.33
26.2
18.9
e9/l
6.6
6.6
0.00
756
7295
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
199
1.90
3.26
1.6
1.6
iu/ml
0.3
0.1
—
6
32
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
103
2.27
3.25
1.1
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
352
3021
1.30
3.24
3.6
2.8
ug/l
91.3
102.8
0.69
324
2812
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
35
186
1.92
3.20
1.2
1.8
g/l
38.6
38.4
0.10
29
165
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
12
5.87
3.02
1.0
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
168
1310
1.36
3.00
2.5
2.5
e6/l
7.1
7.1
0.02
137
1153
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
36
199
1.85
2.94
1.2
2.0
g/l
1.0
0.5
0.19
30
180
(3011397) Hemoglobin [Presence] in Urine by Test strip
189
1508
1.33
2.90
3.2
3.6
—
—
—
0
0
(3000492) Spirometry study
93
665
1.45
2.74
1.5
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
66
2.45
2.72
1.2
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
213
1.77
2.68
1.2
1.8
g/l
9.5
10.3
0.87
30
187
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
391
3456
1.26
2.67
5.7
5.7
umol/l
10.9
10.5
0.50
372
3267
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
22
106
2.11
2.65
1.0
1.0
u/ml
2.2
2.1
—
6
46
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
161
1274
1.33
2.60
1.3
1.3
u/ml
8.3
11.1
0.22
50
504
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
216
1.75
2.56
1.2
1.8
g/l
3.0
3.1
0.33
30
175
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
101
2.11
2.55
1.2
1.1
u/ml
3.1
1.6
—
10
27
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
109
2.05
2.48
1.8
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
16
4.40
2.48
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
61
411
1.52
2.42
1.4
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
117
1.99
2.42
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
117
1.99
2.42
1.2
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
112
849
1.37
2.39
1.9
2.1
ug/g
122.8
112.2
0.09
89
668
(3006462) Nitrate [Presence] in Urine
9
28
3.24
2.31
1.9
3.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
50
326
1.57
2.30
1.4
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
87
636
1.41
2.30
7.6
7.2
mmol/l
1.2
1.5
0.41
68
514
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
230
1937
1.26
2.30
2.2
2.1
u/l
163.9
196.1
0.27
209
1822
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
487
4460
1.24
2.27
3.1
3.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
31
179
1.76
2.25
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
220
1850
1.26
2.22
1.7
1.7
mmol/l
1.3
1.4
0.52
189
1565
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
19
3.71
2.15
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
88
653
1.39
2.15
5.8
3.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
54
365
1.51
2.14
1.0
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
229
1.65
2.12
1.2
1.8
g/l
7.5
7.6
0.05
30
183
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
229
1.65
2.12
1.2
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
229
1.65
2.12
1.2
1.8
g/l
4.3
3.8
0.30
29
173
(3023323) Follitropin [Units/volume] in Serum or Plasma
57
392
1.49
2.09
1.3
1.3
iu/l
30.4
30.8
0.03
44
340
(3021960) Folate [Moles/volume] in Serum or Plasma
178
1470
1.27
2.08
1.4
1.5
nmol/l
19.5
21.6
1.48
155
1246
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
353
3151
1.22
2.01
3.5
3.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
162
1328
1.28
2.01
1.3
1.3
iu/ml
24.3
32.9
0.55
43
427
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
57
2.30
1.98
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
57
2.30
1.98
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
57
2.30
1.98
1.2
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
11
4.57
1.94
4.6
1.5
u/l
307.6
109.1
—
5
11
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
43
283
1.55
1.94
10.5
9.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
33
2.75
1.93
1.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
368
3308
1.21
1.93
5.0
4.8
estimate
0.0
0.0
0.50
67
624
(3025130) Human papilloma virus identified in Specimen
21
113
1.88
1.93
2.0
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
71
518
1.41
1.93
2.2
3.0
g/l
9.7
10.2
0.51
66
482
(3051651) Icteric interference index of Serum or Plasma
10
39
2.58
1.92
2.0
2.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
106
1.91
1.92
1.3
1.1
u/ml
2.7
5.8
0.57
15
37
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
58
2.26
1.91
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
58
2.26
1.91
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
58
2.26
1.91
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
365
3282
1.21
1.90
3.5
3.6
estimate
0.0
0.0
0.00
66
623
(4211845)
9
34
2.67
1.87
1.9
3.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
17
3.55
1.84
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
370
3342
1.20
1.81
3.6
3.6
estimate
0.0
0.0
0.80
66
603
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
33
208
1.61
1.79
1.2
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
24
2.93
1.72
1.3
2.0
ug/l
39.4
55.6
—
7
24
(3029075) Extractable nuclear Ab panel - Serum
7
24
2.93
1.72
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
95
742
1.32
1.70
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
40
268
1.52
1.69
1.6
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
37
244
1.54
1.68
1.5
1.8
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
6
19
3.17
1.66
2.2
6.7
mg/l
92.7
69.1
—
6
11
(3009508) Creatinine [Moles/volume] in Urine
224
1944
1.21
1.64
2.8
3.0
mmol/l
7.1
7.1
0.00
189
1627
(3051611) Lipemic interference index of Serum or Plasma
12
56
2.16
1.61
2.5
2.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
696
6725
1.31
1.60
4.3
4.3
mmol/l
4.8
4.8
0.22
650
6256
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
32
2.52
1.60
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
106
1.81
1.60
1.6
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
211
1827
1.21
1.58
1.4
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
85
662
1.32
1.57
1.8
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
118
960
1.27
1.56
1.9
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
65
486
1.37
1.56
1.4
2.7
g/l
65.8
67.3
0.82
56
447
(3004789) Transferrin [Mass/volume] in Serum or Plasma
107
860
1.28
1.56
2.6
2.2
g/l
2.4
2.4
0.22
98
794
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
33
2.44
1.54
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
33
2.44
1.54
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
44
2.29
1.53
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
71
541
1.34
1.52
3.4
3.5
mmol/l
1.2
1.2
1.39
66
461
(3026008) Bacteria identified in Urine by Culture
234
2054
1.20
1.51
3.3
2.9
—
—
—
0
0
(4268621)
13
65
2.02
1.49
2.4
2.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
66
499
1.35
1.49
2.6
2.9
ug/l
0.7
0.8
0.19
40
308
(3020717) Zinc [Moles/volume] in Serum or Plasma
9
37
2.45
1.48
1.1
1.3
umol/l
49.7
27.5
—
9
37
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
706
6847
1.31
1.47
5.0
4.8
mmol/l
2.9
2.9
0.44
655
6337
(3026389) Candida sp identified in Specimen by Organism specific culture
16
87
1.86
1.46
1.1
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
85
669
1.30
1.46
2.0
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
181
1558
1.21
1.44
2.1
1.7
mg/l
0.9
1.0
0.20
131
1196
(3000991) Gas panel - Venous blood
58
433
1.37
1.42
9.0
7.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
56
416
1.37
1.42
1.4
2.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
271
2423
1.18
1.41
8.7
7.6
inr
1.2
1.2
0.43
65
730
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
111
1.73
1.40
1.4
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
26
166
1.59
1.39
1.5
3.5
mg/l
33.8
42.3
0.53
19
131
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
80
630
1.30
1.38
3.1
4.0
u/l
236.9
251.2
0.30
74
599
(3016018) Differential panel - Cerebral spinal fluid
13
68
1.93
1.34
1.2
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
192
1.53
1.34
1.2
1.4
ug/g
250.3
305.5
0.78
16
114
(3042936) Bacteria identified in Isolate by Culture
108
889
1.25
1.32
2.2
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
45
328
1.39
1.29
2.4
2.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
62
477
1.33
1.27
3.2
2.9
e9/l
3.8
4.0
0.18
54
378
(4034850)
13
229
0.56
1.27
11.5
8.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
152
1303
1.21
1.26
1.4
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
77
1.83
1.26
1.5
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
131
1.62
1.24
2.7
3.4
%
61.3
57.5
0.55
21
131
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.0
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
139
1.60
1.24
5.0
2.5
u/ml
0.4
0.4
—
7
72
(3009214) Lutropin [Units/volume] in Serum or Plasma
23
147
1.58
1.24
1.3
1.2
u/l
18.2
13.4
0.55
18
118
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
36
256
1.43
1.20
2.7
2.9
mmol/l
24.9
24.3
0.63
36
232
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
38
2.12
1.18
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
125
1.62
1.18
2.6
3.0
e9/l
5.0
4.2
0.51
20
125
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
25
166
1.52
1.16
1.5
3.5
mg/l
29.5
25.7
0.40
18
129
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
33
233
1.43
1.15
1.1
1.3
miu/ml
208.9
237.2
0.16
17
110
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
65
1.86
1.14
1.8
1.6
—
—
—
0
0
(4094501)
25
167
1.51
1.13
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
85
694
1.25
1.13
17.6
20.9
inr
1.4
1.2
0.28
12
93
(40760892) CBC W Ordered Manual Differential panel - Blood
179
1574
1.18
1.13
4.8
4.6
—
—
—
0
0
(3002256) Pathology report gross observation
103
862
1.22
1.10
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
27
185
1.48
1.09
2.3
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
1.0
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
24
161
1.51
1.08
1.5
3.6
—
2.1
—
0
18
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
74
1.77
1.07
1.7
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
39
289
1.37
1.05
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
14
227
0.61
1.04
2.6
4.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
68
1.78
1.01
1.4
1.2
u/ml
0.1
1.1
—
7
24
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
687
6693
1.21
1.00
4.3
4.3
mmol/l
1.5
1.5
1.15
637
6195
(3022948) Iron [Moles/volume] in Serum or Plasma
112
955
1.20
1.00
2.8
2.2
umol/l
13.6
13.3
0.17
104
871
(3021788) Differential panel - Synovial fluid
17
107
1.60
1.00
1.4
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
33
240
1.39
1.00
1.7
1.8
g/l
1.4
1.5
0.33
25
206
(3036071) Salmonella sp Ab [Titer] in Serum
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
247
0.64
0.97
1.3
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
53
417
1.29
0.97
1.5
1.8
g/l
1.3
1.4
0.33
47
386
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
25
174
1.45
0.96
6.2
2.1
%
177.4
178.0
0.01
25
166
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
42
321
1.33
0.95
1.3
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
173
1539
1.16
0.95
4.5
4.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
158
1.47
0.94
2.5
2.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
56
446
1.28
0.94
1.9
2.6
e9/l
75.2
71.8
0.21
33
348
(40768793) Breast Pathology biopsy report
15
232
0.64
0.93
1.5
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
16
102
1.58
0.91
1.3
1.4
u/ml
378.0
113.0
—
5
26
(3010421) pH of Blood
9
153
0.58
0.89
6.1
2.8
ph
7.4
7.4
—
9
123
(3003740) Influenza virus B Ag [Presence] in Specimen
18
119
1.52
0.88
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
82
688
1.21
0.88
1.2
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
21
144
1.47
0.88
1.9
1.6
e6/l
1504.6
13102.1
1.95
16
106
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
94
800
1.20
0.88
2.9
2.3
%
22.3
22.7
0.09
74
676
(3027945) Reticulocytes/100 erythrocytes in Blood
74
615
1.22
0.87
2.0
2.7
%
1.7
1.8
0.66
69
540
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
8
43
1.87
0.87
1.1
1.3
—
21.3
—
0
8
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
43
1.87
0.87
1.6
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
44
1.83
0.86
2.3
2.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
200
1811
1.14
0.85
3.0
3.1
mg/l
374.4
280.1
0.10
118
1087
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
94
803
1.19
0.85
1.8
1.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
88
1.60
0.84
2.3
2.6
—
739.6
—
0
7
(3014271) Vancomycin [Susceptibility]
6
31
1.94
0.84
1.8
2.3
—
—
—
0
0
(3036489) Thrombin time
31
231
1.36
0.84
3.7
1.7
s
21.5
20.9
0.38
31
203
(3018405) Lactate [Moles/volume] in Arterial blood
14
214
0.65
0.84
2.3
4.4
mmol/l
1.2
1.2
0.09
14
209
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
32
1.88
0.82
1.5
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
69
576
1.22
0.80
4.9
3.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
61
503
1.23
0.79
2.8
4.4
%
0.0
0.9
0.63
14
114
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
11
66
1.68
0.79
1.3
1.3
g/l
0.5
0.4
0.74
11
49
(3027135) IgG subclass 1 [Mass/volume] in Serum
11
66
1.68
0.79
1.3
1.3
g/l
5.9
7.0
0.73
11
50
(3028192) IgG subclass 2 [Mass/volume] in Serum
11
66
1.68
0.79
1.3
1.3
g/l
2.7
2.7
0.02
11
48
(3044242) Glucose [Moles/volume] in Arterial blood
0
26
0.00
0.78
0.0
4.8
—
—
—
0
0
(3012544) pH of Venous blood
63
522
1.22
0.78
3.0
3.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.1
—
0.3
—
0
22
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
27
0.00
0.77
0.0
1.1
—
110.3
—
0
20
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
27
0.00
0.77
0.0
1.1
—
40.4
—
0
7
(3021440) Promyelocytes/100 leukocytes in Blood
64
532
1.22
0.77
2.8
4.3
%
0.1
0.1
0.52
16
140
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
34
1.77
0.76
1.7
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
23
166
1.40
0.76
1.2
1.1
—
64.7
—
0
17
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
61
507
1.22
0.74
2.7
3.2
mmol/l
2.2
2.2
0.01
40
406
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
28
211
1.34
0.73
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
426
1.24
0.73
1.6
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
61
510
1.21
0.71
2.8
4.1
%
0.8
0.6
0.19
14
107
(3014765) Yersinia sp identified in Stool by Organism specific culture
28
212
1.33
0.71
1.1
1.1
—
—
—
0
0
(4198724)
5
26
1.93
0.70
1.2
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
24
178
1.36
0.69
1.2
1.2
—
1223.3
—
0
9
(4062490)
11
69
1.60
0.68
1.3
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
17
119
1.44
0.67
1.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
66
560
1.19
0.67
2.8
4.2
%
1.1
1.0
0.08
17
156
(3013512) EKG study
202
1862
1.11
0.65
3.5
3.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
95
1.48
0.64
1.9
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
28
216
1.31
0.64
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
237
2540
0.90
0.64
2.5
2.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
29
1.73
0.64
1.2
1.6
nmol/l
97.0
154.4
—
5
29
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
112
1.44
0.64
1.3
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
224
2079
1.11
0.64
2.7
2.3
u/l
52.4
55.9
0.99
209
1921
(3018677) aPTT in Platelet poor plasma by Coagulation assay
102
903
1.15
0.63
3.4
1.8
s
30.8
29.3
0.70
96
870
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
35
434
0.80
0.62
1.6
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
49
1.64
0.62
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
49
1.64
0.62
1.1
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
25
191
1.32
0.61
4.3
1.8
%
94.3
93.7
0.05
25
178
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
88
772
1.16
0.61
1.3
1.7
%
1.4
1.4
0.01
77
678
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
151
0.66
0.60
1.4
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
60
511
1.19
0.60
2.7
3.2
kpa
5.7
5.9
0.69
53
500
(3007853) Bacteria identified in Skin by Aerobe culture
83
728
1.16
0.58
1.8
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
78
682
1.16
0.57
3.6
4.1
%
20.9
21.6
0.20
30
312
(3020682) Albumin/Creatinine [Ratio] in Urine
206
1914
1.10
0.57
3.8
3.9
mg/mmol
6.8
6.6
0.02
112
1142
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
659
6461
1.12
0.57
3.8
3.8
mmol/l
1.2
1.3
0.45
602
5946
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
98
1.44
0.56
1.1
1.3
nmol/l
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
92
816
1.14
0.56
1.8
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
88
0.57
0.56
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
44
525
0.83
0.56
2.2
2.4
ml/min/173m2
65.8
68.5
0.21
18
208
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
97
865
1.14
0.55
4.6
4.6
ug/l
2.8
2.3
0.31
86
762
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
126
0.63
0.54
1.3
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
54
630
0.85
0.54
1.7
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
108
1.40
0.53
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
66
1.52
0.52
2.1
3.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
40
1.50
0.51
1.0
1.3
—
—
—
0
0
(44806118)
11
75
1.47
0.51
2.5
1.5
—
—
—
0
0
(44790049)
11
75
1.47
0.51
2.5
1.5
—
—
—
0
0
(44790047)
11
75
1.47
0.51
2.5
1.5
—
—
—
0
0
(44790048)
11
75
1.47
0.51
2.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
34
279
1.23
0.51
1.1
1.2
—
—
—
0
0
(4306422)
13
93
1.40
0.48
1.2
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
102
1.38
0.47
1.1
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
85
1.42
0.47
1.1
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
129
1.32
0.46
1.5
4.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
14
187
0.74
0.46
2.3
4.3
mmol/l
3.9
3.8
0.25
14
176
(1616796) Gas panel - Central venous blood
8
119
0.67
0.46
6.0
2.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
193
1.25
0.44
1.4
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
73
816
0.88
0.43
7.4
6.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
15
113
1.33
0.43
1.0
1.0
u/ml
2.2
3.3
—
10
48
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
32
1.57
0.42
1.2
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
8
58
1.38
0.41
1.6
9.5
mmol/l
9.4
6.8
—
8
47
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
33
1.52
0.41
1.0
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
62
696
0.88
0.40
1.3
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
104
0.67
0.39
1.7
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
66
590
1.13
0.39
2.3
2.1
g/l
0.2
0.2
0.02
59
553
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
19
0.00
0.39
0.0
1.3
—
0.9
—
0
14
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
89
1.35
0.38
2.3
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
116
1.30
0.37
1.3
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
37
1.35
0.37
2.2
2.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
12
90
1.34
0.36
1.4
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
25
296
0.84
0.33
1.6
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
182
1.21
0.33
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
44
388
1.14
0.33
1.2
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
90
0.66
0.33
1.7
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
101
1.29
0.32
1.1
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
248
2380
1.06
0.31
2.9
3.3
ng/l
24.8
46.9
0.68
129
1521
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
28
239
1.18
0.31
1.6
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
169
1781
0.93
0.31
3.9
4.0
estimate
0.0
0.0
0.80
68
621
(40768800) Prostate Pathology biopsy report
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
156
1.22
0.31
1.4
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
176
1673
1.07
0.30
2.4
2.8
ng/l
1110.7
865.7
0.37
147
1392
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
111
1.27
0.30
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
139
1.23
0.29
1.4
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
140
0.78
0.28
1.1
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
117
0.77
0.27
2.3
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
65
1.23
0.27
1.3
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
122
1.23
0.27
1.7
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
66
1.21
0.26
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
225
1.16
0.26
1.4
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
160
1525
1.06
0.26
1.4
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
71
0.70
0.26
4.0
2.0
pg
31.4
32.2
—
5
71
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
71
0.70
0.26
3.0
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
377
1.12
0.26
1.4
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
25
216
1.16
0.25
1.4
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
137
1442
0.94
0.25
3.6
4.0
kg/l
1.0
1.0
0.57
18
185
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
73
1.24
0.25
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
73
1.24
0.25
1.1
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
51
464
1.11
0.25
8.4
6.7
mmol/l
8.6
8.6
0.03
45
444
(3026493) Urate [Moles/volume] in Serum or Plasma
171
1636
1.06
0.25
2.4
2.4
umol/l
7695.0
5317.5
0.23
153
1406
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
87
1.27
0.24
1.0
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
85
0.70
0.24
1.3
1.9
u/ml
6.8
52.0
—
6
79
(3000330) Specific gravity of Urine by Test strip
26
296
0.87
0.23
3.5
3.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
38
1.32
0.23
1.8
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
38
1.32
0.23
1.4
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
134
1.20
0.23
2.1
2.1
g/l
131.6
130.2
0.08
11
98
(3037756) Immunofixation for Serum or Plasma
15
125
1.20
0.22
1.1
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
79
1.27
0.22
1.6
2.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
18
210
0.85
0.22
1.2
1.4
pmol/l
81.8
237.1
1.19
18
205
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
59
636
0.92
0.21
2.9
4.2
ug/l
11.8
15.2
0.16
46
514
(40758292) HTLV I+II Ab panel - Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
6.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
6.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.4
—
0.5
—
0
7
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
48.3
—
0
6
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
250
2574
0.96
0.21
3.8
3.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
107
1016
1.06
0.21
1.2
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
134
0.82
0.20
4.5
3.8
mg/l
37.6
23.7
—
5
79
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
183
1.15
0.20
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
183
1.15
0.20
1.3
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.2
—
1.7
—
0
14
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44806071)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
49
1.23
0.20
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
51
1.18
0.19
1.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
3.2
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
45
414
1.09
0.19
2.4
2.5
—
—
—
0
0
(4010399)
52
482
1.08
0.19
1.7
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
184
1.15
0.19
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
184
1.15
0.19
1.3
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
6
52
1.16
0.19
1.0
1.1
nmol/l
335.0
401.4
—
6
47
(3019060) Gas panel - Arterial blood
41
376
1.10
0.19
4.2
4.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
58
1.21
0.18
3.1
2.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
60
1.17
0.18
1.1
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
61
1.15
0.17
1.1
1.1
—
61.9
—
0
8
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
7
61
1.15
0.17
1.1
1.1
—
43.2
—
0
5
(4146454)
7
62
1.13
0.17
4.1
2.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
82
1.22
0.17
1.0
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
39
360
1.09
0.16
3.1
3.2
ph
7.4
7.4
—
7
51
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
187
1.13
0.16
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
83
1.21
0.15
1.0
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
49
523
0.93
0.15
4.6
3.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
40
371
1.08
0.15
1.4
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
81
1.11
0.15
1.2
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
89
0.78
0.14
2.7
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
98
0.81
0.13
2.8
1.7
nmol/l
53.5
43.3
—
8
93
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
63
663
0.95
0.13
3.2
3.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
315
1.08
0.13
1.3
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
151
1.13
0.13
1.4
1.4
—
—
—
0
0
(4035726)
62
589
1.06
0.13
1.3
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
107
0.84
0.13
1.0
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
107
0.84
0.13
1.7
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
258
1.09
0.12
1.5
2.0
u/l
217.6
3958.9
—
9
104
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
19
171
1.11
0.12
2.3
3.7
u/ml
16.5
33.9
1.51
19
166
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
152
1.12
0.12
1.4
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
23
210
1.10
0.12
2.4
3.2
g/l
0.1
0.2
1.32
16
69
(3013139) Helicobacter pylori Ag [Presence] in Stool
52
493
1.06
0.12
1.3
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
144
1.11
0.10
1.7
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
44
1.14
0.10
1.0
1.8
%
14.4
10.6
—
5
44
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.6
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
114
0.88
0.09
2.4
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
47
1.06
0.09
1.2
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
145
1.11
0.09
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
184
1.09
0.09
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
20
184
1.09
0.09
2.8
2.5
—
—
—
0
0
(44813793)
6
56
1.07
0.08
1.3
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
62
643
0.96
0.08
1.4
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
144
0.90
0.08
1.5
2.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
85
825
1.03
0.08
4.6
4.4
%
32.6
33.0
0.13
58
543
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.8
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.8
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.8
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
61
0.82
0.08
1.2
3.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
60
0.83
0.08
1.4
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
74
764
0.97
0.08
1.9
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
67
1.05
0.08
1.3
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
68
1.03
0.08
1.6
2.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
75
0.80
0.07
1.5
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
78
1.03
0.07
2.0
2.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
82
0.85
0.07
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
157
1.08
0.07
1.4
1.5
e6/l
11.3
6.4
—
10
123
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
157
1.08
0.07
1.4
1.5
e6/l
681.3
145.1
0.37
11
127
(3022313) Gas panel - Capillary blood
28
265
1.06
0.07
3.5
3.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
128
1.10
0.06
1.0
1.1
u/ml
0.4
2.5
—
8
44
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
101
0.89
0.06
1.2
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
46
477
0.96
0.06
2.2
2.4
ug/l
7.1
5.7
0.27
37
423
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
178
1.07
0.05
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
30
314
0.95
0.05
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
189
1.06
0.04
1.5
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
92
1.09
0.03
1.1
1.2
u/l
14.1
22.9
—
10
79
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
152
1.05
0.02
2.1
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
185
1837
1.01
0.02
3.5
3.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
103
1.07
0.02
1.5
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
136
1370
0.99
0.01
1.6
1.7
pmol/l
105172841.8
22397640.8
0.57
116
1143
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
147
0.95
0.01
1.1
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
12
126
0.95
0.00
3.8
3.8
u/ml
200.3
2317.2
0.56
12
118
(3028300) Cannabinoids [Presence] in Urine
22
226
0.97
0.00
1.5
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
344
1.02
0.00
3.0
3.2
mmol/l
1.7
1.9
0.14
29
259
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
68
686
0.99
0.00
1.7
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
105
1.05
0.00
1.2
1.2
u/ml
356.7
264.7
—
6
65
(1761482) Bacteria [#/volume] in Urine by Culture
15
145
1.04
0.00
6.3
4.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
165
1.03
0.00
1.3
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
106
1.04
0.00
1.7
2.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
106
1.04
0.00
1.4
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
114
0.96
0.00
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
114
0.96
0.00
2.4
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
225
0.98
0.00
1.5
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
225
0.98
0.00
1.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
22
224
0.98
0.00
1.5
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
137
1.02
0.00
2.1
2.4
ug/min
5.3
93.2
—
9
79
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
28
284
0.99
0.00
1.7
1.8
mg/l
2.5
4.8
0.58
18
201
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
33
334
0.99
0.00
1.7
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
108
1.02
0.00
1.6
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
152
0.99
0.00
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
212
0.99
0.00
1.5
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
121
0.99
0.00
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
159
1.01
0.00
2.1
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
171
0.99
0.00
1.6
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
34
339
1.00
0.00
1.3
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
10.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
68
0.88
0.00
1.0
1.2
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
55
0.91
0.00
1.0
1.3
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
6.5
—
0
8
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
120
1.00
0.00
2.2
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
5.6
—
0.2
—
0
9
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
343.6
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
4.8
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
21.0
—
0
5
(3045142) Bone marrow Pathology biopsy report
5
57
0.88
0.00
1.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
83
0.96
0.00
1.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
83
0.96
0.00
1.0
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
84
0.95
0.00
1.0
1.5
—
—
—
0
0
(4015189)
0
9
0.00
0.00
0.0
5.7
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
15.9
—
0
5
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
8
87
0.92
0.00
3.4
3.1
nmol/l
1.0
0.8
—
8
65
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.2
—
1.3
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4281824)
8
83
0.96
0.00
1.3
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
84
0.95
0.00
1.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
85
0.94
0.00
1.0
1.5
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
96
0.94
0.00
1.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
85
0.94
0.00
1.0
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
59
0.85
0.00
1.4
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
69
0.87
0.00
1.3
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(3001556) Androgen free Index in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint E4_GRAVES_OPHT_STRICT and mortality.

Females

Parameter HR [95% CI] p-value
E4_GRAVES_OPHT_STRICT 1.019 [0.88, 1.18] 0.809
Birth year 0.997 [0.99, 1.01] 0.467

During the follow-up period (1.1.1998 — 31.12.2019), 232 out of 2730 females with E4_GRAVES_OPHT_STRICT died.

Males

Parameter HR [95% CI] p-value
E4_GRAVES_OPHT_STRICT 0.955 [0.75, 1.22] 0.706
Birth year 0.988 [0.98, 1.0] 0.021

During the follow-up period (1.1.1998 — 31.12.2019), 86 out of 636 males with E4_GRAVES_OPHT_STRICT died.

Mortality risk

Mortality risk for people of age

years, who have E4_GRAVES_OPHT_STRICT.

N-year risk Females Males
1 0.132% 0.18%
5 0.714% 1.192%
10 1.575% 3.121%
15 2.786% 5.749%
20 5.019% 9.82%

Relationships between endpoints

Index endpoint: E4_GRAVES_OPHT_STRICT – Graves ophthalmopathy, strict

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data